Archives for May 2009
FDA Approves Ankle-Replacement System
The U.S. Food and Drug Administration has approved the Scandinavian Total Ankle Replacement (S.T.A.R.) System for patients with arthritic or deformed ankles.Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.SyntheMed’s REPEL-CV Approved by Australian Regulators
REPEL-CV, an anti-adhesion barrier developed by biomaterials company SyntheMed, has received approval by the Australian Therapeutic Goods Administration for use in open-heart surgery.Explore Investment and Networking Opportunities at IN3 East
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker Instruments, Wright Medical Technology, Integra LifeSciences, and more have already decided to send their teams to the east coast’s largest strategic partnering and investment event, the “Investment In Innovation (IN3) EAST” conference, being held June 23-25, 2009 at The Westin Copley Boston. Meet senior-level medical technology investors, entrepreneurs, and business executives looking to partner, invest and network with the most promising medical technology companies. For more information, visit www.windhover.com/in3east09.
